» Articles » PMID: 27006450

Up-regulation of the Mammalian Target of Rapamycin Complex 1 Subunit Raptor by Aldosterone Induces Abnormal Pulmonary Artery Smooth Muscle Cell Survival Patterns to Promote Pulmonary Arterial Hypertension

Abstract

Activation of the mammalian target of rapamycin complex 1 (mTORC1) subunit Raptor induces cell growth and is a downstream target of Akt. Elevated levels of aldosterone activate Akt, and, in pulmonary arterial hypertension (PAH), correlate with pulmonary arteriole thickening, which suggests that mTORC1 regulation by aldosterone may mediate adverse pulmonary vascular remodeling. We hypothesized that aldosterone-Raptor signaling induces abnormal pulmonary artery smooth muscle cell (PASMC) survival patterns to promote PAH. Remodeled pulmonary arterioles from SU-5416/hypoxia-PAH rats and monocrotaline-PAH rats with hyperaldosteronism expressed increased levels of the Raptor target, p70S6K, which provided a basis for investigating aldosterone-Raptor signaling in human PASMCs. Aldosterone (10(-9) to 10(-7) M) increased Akt/mTOR/Raptor to activate p70S6K and increase proliferation, viability, and apoptosis resistance in PASMCs. In PASMCs transfected with Raptor-small interfering RNA or treated with spironolactone/eplerenone, aldosterone or pulmonary arterial plasma from patients with PAH failed to increase p70S6K activation or to induce cell survival in vitro Optimal inhibition of pulmonary arteriole Raptor was achieved by treatment with Staramine-monomethoxy polyethylene glycol that was formulated with Raptor-small interfering RNA plus spironolactone in vivo, which decreased arteriole muscularization and pulmonary hypertension in 2 experimental animal models of PAH in vivo Up-regulation of mTORC1 by aldosterone is a critical pathobiologic mechanism that controls PASMC survival to promote hypertrophic vascular remodeling and PAH.-Aghamohammadzadeh, R., Zhang, Y.-Y., Stephens, T. E., Arons, E., Zaman, P., Polach, K. J., Matar, M., Yung, L.-M., Yu, P. B., Bowman, F. P., Opotowsky, A. R., Waxman, A. B., Loscalzo, J., Leopold, J. A., Maron, B. A. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.

Citing Articles

Role of Raptor Gene Variants in Hypertension: Influence on Blood Pressure Independent of Salt Intake in White Population.

Aljaibeji H, Heydarpour M, Stanton A, Williams J, Pojoga L, Romero J Hypertension. 2024; 81(5):1167-1177.

PMID: 38497230 PMC: 11023780. DOI: 10.1161/HYPERTENSIONAHA.123.22273.


Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond.

Camarda N, Ibarrola J, Biwer L, Jaffe I Hypertension. 2024; 81(5):1008-1020.

PMID: 38426347 PMC: 11023801. DOI: 10.1161/HYPERTENSIONAHA.123.21358.


Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling.

Lin S, Rue R, Mukhitov A, Goel A, Basil M, Obraztsova K J Clin Invest. 2023; 134(4).

PMID: 38127441 PMC: 10866655. DOI: 10.1172/JCI172116.


Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research.

Mamazhakypov A, Lother A Front Cardiovasc Med. 2023; 10:1118516.

PMID: 36793473 PMC: 9922727. DOI: 10.3389/fcvm.2023.1118516.


Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease.

Wolter N, Jaffe I Am J Physiol Cell Physiol. 2022; 324(1):C193-C204.

PMID: 36440858 PMC: 9902217. DOI: 10.1152/ajpcell.00372.2022.


References
1.
Maron B, Zhang Y, White K, Chan S, Handy D, Mahoney C . Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012; 126(8):963-74. PMC: 3534848. DOI: 10.1161/CIRCULATIONAHA.112.094722. View

2.
McMurtry M, Archer S, Altieri D, Bonnet S, Haromy A, Harry G . Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest. 2005; 115(6):1479-91. PMC: 1136986. DOI: 10.1172/JCI23203. View

3.
Mill C, Monk B, Williams H, Simmonds S, Jeremy J, Johnson J . Wnt5a-induced Wnt1-inducible secreted protein-1 suppresses vascular smooth muscle cell apoptosis induced by oxidative stress. Arterioscler Thromb Vasc Biol. 2014; 34(11):2449-56. DOI: 10.1161/ATVBAHA.114.303922. View

4.
Marsboom G, Toth P, Ryan J, Hong Z, Wu X, Fang Y . Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ Res. 2012; 110(11):1484-97. PMC: 3539779. DOI: 10.1161/CIRCRESAHA.111.263848. View

5.
Sakurabayashi-Kitade S, Aoka Y, Nagashima H, Kasanuki H, Hagiwara N, Kawana M . Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice. Atherosclerosis. 2009; 206(1):54-60. DOI: 10.1016/j.atherosclerosis.2009.01.039. View